Fact CheckerSign in

NCT06329453Recruiting

Intestinal Immunity in Neurologic Disease

Source: ClinicalTrials.gov · Last updated 27 May 2026

Brief summary (registry, in English)

The purpose of this study is to ascertain the functional profiles of the immune cells within the gastrointestinal tract and to determine how these cells contribute to autoimmune and neurologic diseases.

Status (registry)
Recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
29 Jan 2024
Start date
2 Aug 2022
Primary completion date
31 Aug 2027
Lead sponsor
Yale University
NCT number
NCT06329453

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 2 Aug 2022 to the primary completion date, 31 Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently pregnant. Women of childbearing potential would perform a point of care urine pregnancy test prior to colonoscopy/endoscopy.
  • Systemic corticosteroid use (equivalent of prednisone 10 mg per day or higher for \>5 days) within 2 weeks of colonoscopy

Other illness

  • Known or suspected, chronic inflammatory gastrointestinal disease (e.g. inflammatory bowel disease)
  • Known, acute or chronic infections
  • Malignancy, diagnosed or treated within the last 5 years
  • History of major GI surgery (e.g. colon resection, gastric bypass)
  • Bleeding disorder, or on anticoagulant medication
  • Other medical condition that, in the judgement of the investigator, would lead to higher-than-expected risks of biopsy
  • Allergy to MAC anesthesia or other drugs used pursuant to standard of care for biospecimen collection

Other

  • Systemic antibiotic (PO or IV) use within 3 months of colonoscopy
  • Probiotic use within 2 weeks of procedure

Who the study is looking for

  • Age 18 and up
    • ONE of the following:
  • Recommended to under a screening colonoscopy (+/- upper endoscopy) as part of standard of care. This includes healthy individuals as well as those with neurologic and/or autoimmune diseases. OR
  • Willing to undergo research colonoscopy (+/- upper endoscopy) for research

Age in the registry: 18 years to 99 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Yale MS Clinic
Coordinator of this site? Confirm its status
North HavenUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.